Kathleen Pritchard

A priori Prediction of Neoadjuvant Chemotherapy Response and Survival in Breast Cancer Patients using Quantitative Ultrasound

Mehrdad J. Gangeh, Gregory J. Czarnota, Ali Sadeghi-Naini, 2017, Scientific Reports.

Chemotherapy-Response Monitoring of Breast Cancer Patients Using Quantitative Ultrasound-Based Intra-Tumour Heterogeneities

Gregory J. Czarnota, Michael C. Kolios, Ali Sadeghi-Naini, 2017, Scientific Reports.

Randomized phase II study comparing two schedules of everolimus in patients with recurrent/metastatic breast cancer: NCIC Clinical Trials Group IND.163.

Eric Sauerbrei, Stephen Chia, Karen A Gelmon, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ?

Jean-Philippe Pignol, Alina Mihai, Lawrence Paszat, 2004, Breast Cancer Research and Treatment.

The global breast cancer burden: variations in epidemiology and survival.

Dino Amadori, D. Amadori, G. Hortobagyi, 2005, Clinical breast cancer.

Early prediction of therapy responses and outcomes in breast cancer patients using quantitative ultrasound spectral texture

Martin J. Yaffe, Gregory J. Czarnota, Michael C. Kolios, 2014, Oncotarget.

Quantitative ultrasound assessment of breast tumor response to chemotherapy using a multi-parameter approach

Gregory J. Czarnota, Ali Sadeghi-Naini, Lakshmanan Sannachi, 2016, Oncotarget.